baber/WOPTO huggingface dataset:
Patent CA-2582575-A1 (CA)
Inventor: LEUTWYLER ANDRE
IPC: E03D3/12
Filed: 2007-03-22
Abstract: The internal housing (12) according to the invention for a sanitary fitting has a receiving opening (14) intended to receive a control cartridge (16). The receiving opening (14) is bounded along its circumference by a wall (20) and at its lower end by a base (22). In order to supply water to the control cartridge (16), the internal housing (12) has an inlet opening (26) passing through the base (22). A discharge opening (40) for the discharge of the water flowing out from the control cartridge (16) also passes through the base (22). In order to ensure a leak-tight transition between the internal housing (12) and the control cartridge (16), an inlet seal groove (57) open on its upper side and completely surrounding the inlet opening (26), and a discharge seal groove (60) open on its upper side and completely surrounding the discharge opening (40) are formed in the base (22). The inlet seal groove (57) is intended to receive an inlet seal element (54') and the discharge seal groove (60) is intended to receive a discharge seal element (54" ) that consequently bear on the one hand against the internal housing (12) and on the other hand against the control cartridge (16).   (Fig. 1)
Patent CA-2582943-A1 (CA)
Title: Mobile phone with sensor for detection of user's handling
Inventor: FOURESTIER VINCENT
IPC: H04M1/72448
Filed: 2007-03-28
Abstract: The invention relates to a mobile phone comprising at least one sensor (S1-S6) adapted to detect by direct contact that a user is handling said mobile phone, and processing means adapted to modify at least an user's interface functionality of said mobile phone depending on the detection.
Patent CA-2583023-A1 (CA)
Title: A top-up container assembly
Inventor: ETESSE PATRICK JEAN-FRANCOIS
IPC: B65D47/24
Filed: 2005-10-05
Abstract: The present invention relates to a top-up container assembly (1) comprising a bottle (20) having a bottom surface (22), and a top surface (21) having an opening located away from said bottom surface (22); and a dispensing cap (30) attached to said top surface (21) of said bottle (20), said dispensing cap (30) comprising a housing (31) and a valve (32), wherein at least a portion of said housing (31) is transparent and/or translucent, and wherein said valve (32) is visually distinctive from said housing (31), to enable a user of said top-up container assembly (1) to see the valve (32) through the housing (31).  The present invention also relates to the use of a dispensing cap (30) for dispensing a dishwashing cleaning composition, to a dishwashing cleaning product, and to a method of cleaning dishware.
Patent CA-2584042-A1 (CA)
Title: Tube multicouche tpe/pp/renfort
Inventor: DABOUINEAU JOHANN
IPC: B32B27/32
Filed: 2005-10-19
Abstract: Tube multicouche comportant de l'intérieur vers l'extérieur : - une couche interne en élastomère thermoplastique (1) compatible avec le polypropylène, - une couche intermédiaire en polypropylène (2) en contact direct avec la couc he interne, - une couche externe de renfort (4).
Patent CA-2584128-A1 (CA)
Title: Process for producing penam compound
Inventor: TOKUMARU YOSHIHISA
IPC: C07B53/00
Filed: 2005-10-25
Abstract: An industrially advantageous process for efficiently producing a 2.alpha.-methyl-2.beta.-[(1,2,3-triazol-1-yl)methyl]penam-3.alpha.~carboxylic acid ester as the target compound while significantly inhibiting an undesirable cepham compound from generating as a by-product. Diphenylmethyl 2.beta.-bromomethyl-2.alpha.-methylpenam-3.alpha.-carboxylate (BMPB) is reacted with 1,2,3-triazole in a halogenated hydrocarbon at -5~C or lower. By conducting the reaction in a halogenated hydrocarbon at -5~C or lower, the generation of an undesirable cepham compound as a by-product can be significantly inhibited, whereby the target diphenylmethyl 2.alpha.-methyl-2.beta.-[(1,2,3-triazol-1-yl)methyl]penam-3.alpha.~carboxylate (TMPB) can be efficiently produced.
Patent CA-2587136-A1 (CA)
Inventor: YEE CASSIAN
IPC: G01N33/50
Filed: 2005-11-23
Abstract: Methods for preparing ex vivo T cell cultures using IL-21 compositions for use in adoptive immunotherapy are described. Addition of IL-21 to cultures of non-terminally differentiated T cells population, either isolated or present in peripheral blood mononuclear cells are exposed to one or more tumor antigens, and in the presence of IL-21 compositions and antigen presenting cells (APCs), the resulting T cell population has an enhanced antigen-specificity, and can be reintroduced into the patient. Methods are also disclosed for identifying tumor antigens by culturing T cell populations exposed to IL-21 compositions and APCs in the presence of tumor material.
Patent CA-2589481-A1 (CA)
Inventor: NAMGOONG JOHN E
IPC: H01M50/291
Filed: 2005-11-08
Abstract: A battery cartridge includes a pair of outer frame members for receiving unit cells and an inner frame member disposed between the outer frame members. The unit cells are mounted between the outer and inner frame members. The inner frame member has a plurality of through-holes, which communicate with the outside while the unit cells are mounted between the outer and inner frame members. An opened type battery module includes such a battery cartridge. The battery cartridge and the battery module have a high structural integration and mechanical strength. Consequently, the present invention has the effect of minimizing the size of a battery system, stably mounting unit cells having low mechanical strength, and effectively removing heat from the unit cells.
Patent CA-2590228-A1 (CA)
Title: Method and apparatus for implementing automatic display of help information with detection of error condition for meter connection
Inventor: TRZYBINSKI ROBERT
IPC: G06F19/00
Filed: 2005-12-12
Abstract: A method and apparatus are provided for implementing automatic display of assistance information in a data collection computer system. A predefined port is monitored to detect the connection of a meter. When a meter connection is identified and the meter is not communicating properly, assistance information is automatically displayed for the user. A switch is provided for electromechanically detecting when an attempt is being made to connect a meter of a user selected type to a serial port of the data collection computer system. Then help information is automatically displayed when an error is detected.
Patent CA-2591013-A1 (CA)
Inventor: OWEN RUSSELL
IPC: H04W8/08
Filed: 2007-05-28
Abstract: A system and method for managing mobile device communication in an enterprise includes a device management agent and a synchronization agent in the mobile device. Information about the status of the mobile device is collected by the device management agent and the synchronization agent communicates the status information to the enterprise with which the mobile device is associated. A  synchronization server at the enterprise collects device information and updates records at the enterprise. Information such as device telephone number is propagated to the enterprise directory and potentially to a PBX to ensure connectivity with the mobile device.
Patent CA-2592953-A1 (CA)
Inventor: VAN-GELDER JOEL M
IPC: A61K31/426
Filed: 2006-01-05
Abstract: Disclosed are novel rigidified compounds having a rhodanine-like residue and at least one aryl or heteroaryl residue linked to the rhodanine-like residue, whereby a core structure of these compounds, as defined in the specification, is characterized as having one or zero free-to-rotate bonds. Also disclosed are pharmaceutical compositions containing these rigidified compounds and uses thereof for modulating the activity of heparanase and hence in the treatment of heparanase-associated diseases and disorders, and uses thereof for modulating the activity of heparin-binding proteins and hence in the treatment of heparin-binding proteins-associated diseases and disorders as well as in the treatment of medical conditions that are at least partially treatable by rhodanine or a rhodanine analog.
Patent CA-2594629-A1 (CA)
Inventor: ITO KEN-ICHI
IPC: A61P43/00
Filed: 2005-09-09
Abstract: A pharmaceutical preparation comprising a hepatocellular growth factor, or DNA  coding for the same, or the like is capable of inhibiting any fibrosis of implanted organ after organ transplantation. The pharmaceutical preparation is useful in the field of organ transplantation and the field of regeneration medicine.
Patent CA-2595113-A1 (CA)
Title: Managing risks within variable annuity contracts
Inventor: COUGHLIN JOHN L
IPC: G06Q40/00
Filed: 2006-01-13
Abstract: A method for mitigating risks associated with a reinsured annuity contract includes reinsuring variable annuity contracts having guaranteed minimum death benefits, calculating risk statistics based on one or more characteristics of the plurality of guaranteed minimum death benefit variable annuity contracts, determining a set of market indices that model the performance of the reinsured variable annuity contracts based on the plurality of risk statistics, and hedging the risks associated with the reinsured variable annuity contracts by purchasing on or more option contracts based on the determined market indices.
Patent CA-2596728-A1 (CA)
Inventor: OKUYAMA KEIICHI
IPC: H03L7/14
Filed: 2007-08-09
Abstract: The present invention provides a clock supply device and a clock supply method by which the holdover characteristics that maintains with high precision the same frequency as the frequency observed immediately before an error can be achieved simply with the addition of a high stability oscillator. An output clock signal that is output from a conventional PLL circuit is monitored with a clock signal of a high-stability fixed oscillator, and the monitor result is written in a memory. A holdover reference generating circuit averages the result written over a certain period of time. When a frequency error monitoring circuit detects a frequency error in an input reference signal, a selector selects a holdover reference, instead of the input reference signal, and inputs the holdover reference to the PLL circuit.  Alternatively, the holdover reference generating circuit may select the input of the PLL circuit at the time of an error, and then perform holdover.
Patent CA-2598019-A1 (CA)
Inventor: MIMRAN ARIK
IPC: H04B17/00
Filed: 2006-02-16
Abstract: Operating a communication device in a half-duplex mode using only overhead channels; and substantially free running a timing reference obtained during reception to allow a timing reference value to drift during transmission.
Patent CA-2598132-A1 (CA)
Inventor: CHAWLA SACHINDER S
IPC: H04L9/00
Filed: 2006-03-09
Abstract: A computer readable medium includes executable instructions to audit data migration. The executable instructions include instructions to define a data migration path from a source to a target. Audit points are specified within the data migration path. Audit statistics to be generated at the audit points are identified. The audit statistics including data corresponding to individual data values transmitted over the data migration path. Audit rules to be applied against the audit statistics are established.
Patent CA-2598332-A1 (CA)
Inventor: THEIS RICHARD
IPC: B22D11/103
Filed: 2006-12-14
Abstract: Disclosed is a tundish car comprising a lifting mechanism (1) for a tundish (2) used for liquid steel materials, especially in a multistrand continuous casting plant. The tundish (2) is supported on a traveling frame (7) such that the same can be raised and lowered by means of controlled electromechanical or hydraulic lifting mechanisms (1a, 1b). In order to dispense with the need for a quadruple arrangement of piston-cylinder drives and a complicated synchronization control while ensuring safety for personnel and simplifying the design, a single lifting support (9) and only two lifting mechanisms (1a, 1b) are provided.
Patent CA-2598458-A1 (CA)
Title: Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
Inventor: ANILKUMAR GOPINADHAN N
IPC: A61K31/495
Filed: 2006-02-14
Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula (1):  Chemical formula should be inserted here as it appears on the abstract in paper form. and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non limiting example(s) include, psoriasis), autoimmune diseases (non limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.g., tuberculoid leprosy), fixed drug eruptions, cutaneous delayed-type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula (1).
Patent CA-2599146-A1 (CA)
Inventor: JACKWOOD DARALM J
IPC: C12Q1/70
Filed: 2006-02-24
Abstract: Methods of identifying animals infected with a vvIBDV are provided. The methods comprise contacting a nucleic acid sample obtained from the animal or a nucleic acid product obtained by amplifying RNA obtained from the animal with one or more probe pairs, each of which comprises a mutation probe and an anchor probe, and then determining the melting temperature of any hybridization complex that is formed when the one or more probe pairs hybridize with a nucleic acid in the sample. Such determination is made using FRET analysis. In one embodiment the mutation probe comprises a sequence identical to a first mutated target sequence of SEQ ID NO: 1 in which the cytosine at position 827 is substituted with a thymidine, the cytosine at position 830 is substituted with a thymidine, and the thymidine at position 833 is substituted with a cytosine, or the reverse complement thereof. In another embodiment, the mutation probe comprises a sequence identical to a second mutated target sequence of SEQ ID NO: 1 in which the guanine at position 897 is substituted with an adrenine, the cytosine at position 905 is substituted with a thymidine, and the cytosine at position 908 is substituted with an thymidine. Also, provided herein are kits containing nucleotide probe pairs that can be used in the present methods.
Patent CA-2600286-A1 (CA)
Inventor: BAUER JOERG
IPC: C12P7/64
Filed: 2006-03-21
Abstract: The invention relates to a method for producing polyunsaturated C20- or C22-fatty acids in transgenic plants, whereby nucleic acids coding for polypeptides with .about.-6-desaturase, .about.-6-elongase, .about.-5-desaturase, .about.-5-elongase, .about.-4-desaturase, .about.-12-desaturase and .omega.-3-desaturase activity are introduced into the plants and wherein the nucleic acid coding for the .about.-12-desaturase is represented by SEQ ID NO: 25 and homologs thereof.  Advantageously, said desaturases and elongases come from phytophtora sojae.  The invention also relates to nucleic acid sequences, nucleic acid constructs, vectors and organisms containing the inventive nucleic acid sequences, vectors containing the nucleic acid sequences and/or the nucleic acid constructs, and transgenic plants containing the cited nucleic acid sequences, nucleic acid constructs and/or vectors. The invention further relates to fatty acid compositions produced according to the inventive method, and to the use thereof.
Patent CA-2600476-A1 (CA)
Title: Interpolated frame deblocking operation in frame rate up conversion application
Inventor: RAVEENDRAN VIJAYALAKSHMI R
IPC: H04N19/895
Filed: 2006-03-10
Abstract: A method and apparatus to enhance the quality of interpolated video, constructed from decompressed video data, comprising denoising the interpolated video data, is described. A low pass filter is used to filter the interpolated video data. In one embodiment, the level of filtering of the low pass filter is determined based on a boundary strength value determined for the interpolated video data and neighboring video data (interpolated and/or non-interpolated). In one aspect of this embodiment, the boundary strength is determined based on proximity of reference video data for the interpolated video data and the neighboring video data.
Patent CA-2601056-A1 (CA)
Inventor: ROGERS BURL A
IPC: B64C25/62
Filed: 2002-04-26
Abstract: A shock absorber that uses polyurethane discs for aircraft landing gear. The discs are maintained under compression. When the aircraft lands or taxis, loads further compress the discs. Unlike bungee cords, however, the discs do not release their energy immediately. Rather, they release the energy slowly, which produces a smoother reaction to loads that eliminates any bounce back of the aircraft.
Patent CA-2602352-A1 (CA)
Inventor: SABAHI MAHMOOD
IPC: C07C249/02
Filed: 2005-12-30
Abstract: This invention provides aromatic diimines where the diimines have imino groups with at least two carbon atoms, and either are in the form of one benzene ring having two imino groups on the ring, which imino groups are meta or para relative to each other, and in which each position ortho to an imino group bears a hydrocarbyl group, or are in the form of two benzene rings connected by an alkylene bridge and having one imino group on each ring, and in which each position ortho to an imino group bears a hydrocarbyl group. This invention also provides aromatic secondary diamines where the diamines have amino hydrocarbyl groups with at least two carbon atoms, and either are in the form of one benzene ring having two amino groups on the ring, which amino groups are meta or para relative to each other, and in which each position ortho to an amino group bears a hydrocarbyl group, or are in the form of two benzene rings connected by an alkylene bridge and having one amino group on each ring, and in which each position ortho to an amino group bears a hydrocarbyl group. Also provided are processes for forming diimines and secondary diamines from primary diamines, including the aromatic diimines and aromatic secondary diamines of the invention.
Patent CA-2604893-A1 (CA)
Title: Radially extended support member for spinal nucleus implants and methods of use
Inventor: GONTARZ GERALD
IPC: A61L27/54
Filed: 2007-02-09
Abstract: A spinal nucleus implant is provided which includes an implant body and an interiorly embedded support member which extends out from the implant body. In one embodiment, the support member is fabric selected from the group consisting of mesh, woven fabric and nonwoven fabric. In one embodiment, the support member includes at least one portion which is located outside of the body, said portion adapted to engage one or more guides for orienting the implant. In one embodiment, the implant is capable of expanding from a compact, substantially dehydrated configuration to an expanded hydrated configuration. A method of manufacturing a spinal nucleus implant is provided which includes coagulating a liquid polymer such that at least a portion of said support member extends beyond the perimeter of the polymer to form a spinal nucleus implant having an interiorly disposed support member which extends out of the polymer. A method of implanting such a spinal nucleus implant is provided.
Patent CA-2606227-A1 (CA)
Inventor: DEVEMY EMMANUELLE MARIE-MADELE
IPC: A61K38/03
Filed: 2006-04-28
Abstract: Peptides comprising a cadherin cell adhesion recognition (CAR) sequence, and compositions comprising such peptides, are provided. Methods of using such peptides for modulating cadherin-mediated processes in a variety of therapeutic contexts are also provided. Methods are also provided for identifying compounds that are capable of modulating cadherin-mediated processes.
Patent CA-2606469-A1 (CA)
Inventor: SIEGFRIED DANIEL ELIOT
IPC: B05B11/00
Filed: 2006-04-18
Abstract: An apparatus for dispensing a liquid product having: a) housing or frame having an opening (3a) , b) a receptacle for the liquid with a feed nozzle arranged substantially stationary with respect to the housing or frame, c) a dosing chamber (7) having a valve containing at least a first orifice and a second orifice, d) a mechanism arranged to allow ejection of liquid through the second orifice, and e) a through passage arranged to allow the ejected liquid to pass in a direction different from the feed nozzle and out of the opening (3a) , wherein i) the mechanism comprises a mobile element movable with respect to the housing or frame between at least a first position in which the first orifice of the dosing chamber and the feed nozzle are in flow communication and a second position in which the second orifice and the through passage are in flow communication, and N) the mechanism is arranged to allow aspiration of liquid through the first orifice when the mobile element is in the first position and ejection of liquid through the second orifice when the mobile element is in the second position.
Patent CA-2607579-A1 (CA)
Inventor: SOHN LYDIA L
IPC: C12Q1/70
Filed: 2006-05-05
Abstract: An apparatus for characterizing and identifying individual particles, including: an input reservoir; at least one output reservoir; a channel connecting the input reservoir to the at least one output reservoir, wherein the channel is functionalized with at least one molecule selected to interact with a marker on a surface of a particle; a system to move fluid containing the particle from the input reservoir through the channel and into the at least one output reservoir; and a system to measure the period of time during which the particle moves through the channel. The particle may optionally be a cell, the at least one molecule may be a protein functionalized onto the channel to interact with the protein on the surface of the cell so as to slow passage of the target cell through the channel. By measuring the period of time during which the particle takes to move through the channel, the particle can be characterized and thereby identified.
Patent CA-2612957-A1 (CA)
Title: Immunogenic composition comprising neisseria meningitidis capsular saccharide conjugates
Inventor: DUVIVIER PIERRE
IPC: A61K39/116
Filed: 2006-06-23
Abstract: The present application discloses an immunogenic composition comprising at least 2 different N. meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW  which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 1:2-1:5, and one or more different saccharides is/are selected from a second group consisting of MenA, MenC, MenY and MenW which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 5:1-1:1.99.
Patent CA-2616077-A1 (CA)
Title: Waste disposal method and device
Inventor: ORAWETZ RONALD
IPC: B03B5/28
Filed: 2006-04-10
Abstract: Disclosed are a waste disposal method and device having the following characteristics: a) a water basin (2, 2a, 2b, 2c) for separating metal components; b) a water basin (3) for separating plastic components and minerals; c) mills (3b, 3d) for processing the plastic components into granulate; d) a mill (4) for comminuting the remaining waste; e) a drying stage (5) for drying the remaining waste; f) a stage (6) for removing ashes from the dried waste; g) a mixing stage (7) for mixing the ash-free waste with plastic granulate and sewage sludge at an adjustable ratio; a press (8) for shaping the mixed product into pellets; i) a stage for burning (9) the pellets in order to generate power.